Treatment Individualization in Colorectal Cancer

por van Geel, Robin M. J. M., Beijnen, Jos H., Bernards, René, Schellens, Jan H.M.
Publicado 2015

Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands

por Oelen, Yrina, Revenberg, Sven, de Vos-Geelen, Judith, van Geel, Robin, Schoenmaekers, Janna, van den Beuken-Everdingen, Marieke, Valkenburg-van Iersel, Liselot
Publicado 2022

Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer

por Otten, Leila S., Piet, Berber, van den Heuvel, Michel M., Marzolini, Catia, van Geel, Robin M.J.M., Gulikers, Judith L., Burger, David M., Leentjens, Jenneke, ter Heine, Rob
Publicado 2022

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cance...

por van Geel, Robin M. J. M., van Brummelen, Emilie M. J., Eskens, Ferry A. L. M., Huijberts, Sanne C. F. A., de Vos, Filip Y. F. L., Lolkema, Martijn P. J. K., Devriese, Lot A., Opdam, Frans L., Marchetti, Serena, Steeghs, Neeltje, Monkhorst, Kim, Thijssen, Bas, Rosing, Hilde, Huitema, Alwin D. R., Beijnen, Jos H., Bernards, René, Schellens, Jan H. M.
Publicado 2020

A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer

por ter Heine, Rob, van den Heuvel, Michel M., Piet, Berber, Deenen, Maarten J., van der Wekken, Anthonie J., Hendriks, Lizza E. L., Croes, Sander, van Geel, Robin M. J. M., Jansman, Frank G. A., Boshuizen, Rogier C., Franssen, Eric J. F., Smit, Arthur A. J., Dumoulin, Daphne W., Oude Munnink, Thijs H., Smit, Egbert F., Derijks, Hieronymus J., van der Leest, Cor H., Hendrikx, Jeroen J. M. A., Moes, Dirk J. A. R., de Rouw, Nikki
Publicado 2023